Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):971–981. doi: 10.1002/pds.1637

Figure 2. Frequency of Coadministration of QT-interval prolonging drugs.

Figure 2

Frequency of QT-interval prolonging drug coadministration is illustrated (as a percentage of all patients receiving the individual agent) with duration of coadministration (mean (±SE) days). Drug designations are as noted in Table 1 and Figure 1.

HHS Vulnerability Disclosure